Published in Circulation on February 23, 2009
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol (2013) 1.46
A 35-Year Perspective (1975 to 2009) into the Long-Term Prognosis and Hospital Management of Patients Discharged from the Hospital After a First Acute Myocardial Infarction. Am J Cardiol (2015) 1.45
Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008. Am Heart J (2014) 1.42
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Crit Care (2016) 1.41
Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med (2016) 1.18
The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest (2011) 1.16
Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med (2010) 1.07
Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc (2014) 1.06
Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States. J Am Heart Assoc (2014) 0.95
Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care (2011) 0.93
Recent trends in post-discharge mortality among patients with an initial acute myocardial infarction. Am J Cardiol (2012) 0.91
Effect of early statin treatment in patients with cardiogenic shock complicating acute myocardial infarction. Korean Circ J (2013) 0.90
Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail (2014) 0.90
Positive predictive value of International Classification of Diseases, 10th revision, diagnosis codes for cardiogenic, hypovolemic, and septic shock in the Danish National Patient Registry. BMC Med Res Methodol (2015) 0.89
Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term: an updated meta-analysis. Medicine (Baltimore) (2015) 0.88
Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol (2014) 0.86
Decade-Long Trends in 30-Day Rehospitalization Rates After Acute Myocardial Infarction. J Am Heart Assoc (2015) 0.84
Encouraging trends in acute myocardial infarction survival in the oldest old. Am J Med (2013) 0.83
FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock. Eur Heart J Acute Cardiovasc Care (2013) 0.83
Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Neth Heart J (2012) 0.82
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Crit Care (2014) 0.82
Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock. BMC Anesthesiol (2014) 0.82
Mechanical circulatory support in acute cardiogenic shock. F1000Prime Rep (2014) 0.80
Trends in early aspirin use among patients with acute myocardial infarction in China, 2001-2011: the China PEACE-Retrospective AMI study. J Am Heart Assoc (2014) 0.79
Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock. Biomed Res Int (2016) 0.79
Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support. Yonsei Med J (2014) 0.79
Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol (2016) 0.79
Thirty-day Hospital Readmissions in Patients with Non-ST-segment Elevation Acute Myocardial Infarction. Am J Med (2015) 0.78
The Use of Intra-aortic Balloon Pump in a Real-World Setting: A Comparison between Survivors and Nonsurvivors from Acute Coronary Syndrome Treated with IABP. The Jakarta Acute Coronary Syndrome Registry. Int J Angiol (2013) 0.78
30-year trends in patient characteristics, treatment practices, and long-term outcomes of adults aged 35 to 54 years hospitalized with acute myocardial infarction. Am J Cardiol (2014) 0.78
Increase in the proportion of patients hospitalized with acute myocardial infarction with do-not-resuscitate orders already in place between 2001 and 2007: a nonconcurrent prospective study. Clin Epidemiol (2012) 0.78
Survival after hospital discharge for ST-segment elevation and non-ST-segment elevation acute myocardial infarction: a population-based study. Clin Epidemiol (2013) 0.78
Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol (2016) 0.78
Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study. Crit Care (2015) 0.77
Temporal Trends of In-Hospital Mortality in Patients Treated with Intra-Aortic Balloon Pumping: A Nationwide Population Study in Taiwan, 1998-2008. PLoS One (2015) 0.77
Efficacy of Intra-aortic Balloon Pump before versus after Primary Percutaneous Coronary Intervention in Patients with Cardiogenic Shock from ST-elevation Myocardial Infarction. Chin Med J (Engl) (2016) 0.77
Six-month mortality and cardiac catheterization in non-ST-segment elevation myocardial infarction patients with anemia. Coron Artery Dis (2011) 0.77
Cardiogenic Shock with Complete Atrio-ventricular Block in an Octogenarian Woman: Are we going too far? Oman Med J (2014) 0.77
Decade-Long Trends in the Frequency of 90-Day Rehospitalizations After Hospital Discharge for Acute Myocardial Infarction. Am J Cardiol (2015) 0.77
Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome? Crit Care (2013) 0.77
Interventional therapies in acute myocardial infarction complicated by cardiogenic shock. Herz (2016) 0.77
Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care (2012) 0.76
Intra-aortic balloon counterpulsation in acute myocardial infarction: old and emerging indications. Neth Heart J (2013) 0.76
Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes (2016) 0.76
Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization. PLoS One (2016) 0.75
Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China. Exp Ther Med (2016) 0.75
Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction. Diab Vasc Dis Res (2014) 0.75
Is Intra-Aortic Balloon Pump Counterpulsation Sufficient to Treat Patients in Cardiogenic Shock, Undergoing Primary Percutaneous Coronary Intervention. Cardiol Res (2015) 0.75
Early Prediction of 3-month Survival of Patients in Refractory Cardiogenic Shock and Cardiac Arrest on Extracorporeal Life Support. Indian J Crit Care Med (2017) 0.75
Circulating bile acids predict outcome in critically ill patients. Ann Intensive Care (2017) 0.75
An unusual case of renal calculi leading to myocardial infarction and cardiogenic shock. World J Emerg Med (2017) 0.75
Risk factors and clinical characteristics of in-hospital death in acute myocardial infarction with IABP support. Int J Clin Exp Med (2015) 0.75
Magnitude, treatment, and impact of diabetes mellitus in patients hospitalized with non-ST segment elevation myocardial infarction: A community-based study. Diab Vasc Dis Res (2015) 0.75
Statins for patients with cardiogenic shock. Korean Circ J (2014) 0.75
Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysis. World J Cardiol (2016) 0.75
ECMO in cardiac arrest and cardiogenic shock. Herz (2017) 0.75
Characteristics, treatment practices, and in-hospital outcomes of older adults hospitalized with acute myocardial infarction. J Am Geriatr Soc (2014) 0.75
Effects of thrombin and thrombin receptor activation on cardiac function after acute myocardial infarction. Am J Transl Res (2015) 0.75
Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study. Exp Clin Cardiol (2013) 0.75
The outcomes of intra-aortic balloon pump usage in patients with acute myocardial infarction: a comprehensive meta-analysis of 33 clinical trials and 18,889 patients. Patient Prefer Adherence (2016) 0.75
Extracorporeal life support with left ventricular decompression-improved survival in severe cardiogenic shock: results from a retrospective study. PeerJ (2017) 0.75
Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis. J Int Med Res (2016) 0.75
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA (2007) 6.06
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 4.00
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA (2005) 2.56
Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med (1999) 2.46
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA (2006) 2.35
A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol (2004) 2.10
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation (1995) 2.07
Emergency cardiac procedures in patients in cardiogenic shock due to complications of coronary artery disease. Circulation (1989) 1.99
Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med (1991) 1.99
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol (1992) 1.31
Cardiogenic shock. N Engl J Med (1994) 1.05
Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J (2006) 1.00
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99
The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol (1989) 0.98
Angioplasty therapy of cardiogenic shock: are randomized trials necessary? J Am Coll Cardiol (1992) 0.98
Cardiogenic shock: current understandings and future research directions. Am J Cardiol (1994) 0.86
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA (2004) 7.32
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA (2007) 6.06
Risk factors for venous thromboembolism. Circulation (2003) 4.64
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol (2002) 3.45
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 3.41
Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2005) 2.94
Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med (2004) 2.80
Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med (2011) 2.65
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med (2015) 2.63
A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes (2009) 2.53
Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J (2010) 2.52
Venous thromboembolism in the outpatient setting. Arch Intern Med (2007) 2.46
Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J (2008) 2.33
Predicting deep venous thrombosis in pregnancy: out in "LEFt" field? Ann Intern Med (2009) 2.26
The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med (2006) 2.21
External validity of clinical trials in acute myocardial infarction. Arch Intern Med (2007) 2.14
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation (2007) 2.12
A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol (2004) 2.10
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J (2003) 1.94
Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med (2005) 1.90
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J (2008) 1.86
Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation (2002) 1.82
Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med (2007) 1.81
Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med (2013) 1.79
Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis (2009) 1.71
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67
Hospital transfer of patients with acute myocardial infarction: the effects of age, race, and insurance type. Am J Med (2002) 1.66
Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J (2009) 1.66
The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J (2009) 1.57
Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med (2004) 1.57
Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. Eur Heart J (2009) 1.53
Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost (2011) 1.52
Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. Am Heart J (2002) 1.51
Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes (2009) 1.51
Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens (2015) 1.45
Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol (2009) 1.45
Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol (2003) 1.44
Outcomes from patients with multi-vessel disease following primary PCI: staged PCI imparts very low mortality. Catheter Cardiovasc Interv (2011) 1.44
Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events. Circulation (2005) 1.42
In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events. Rev Esp Cardiol (2009) 1.42
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J (2005) 1.39
30-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol (2011) 1.39
Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2004) 1.39
Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol (2008) 1.36
Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med (2008) 1.36
Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2004) 1.34
Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med (2008) 1.32
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 1.31
Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. Ann Emerg Med (2002) 1.25
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ (2005) 1.20
Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J (2004) 1.19
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol (2005) 1.19
Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2009) 1.18
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med (2004) 1.17
The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest (2011) 1.16
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol (2015) 1.15
Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. Am Heart J (2006) 1.14
Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J (2009) 1.13
Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J (2005) 1.13